Skip to main content

How pre-analytical conditions impact glucose measurement and (gestational) diabetes diagnosis: A real-world stability study and a call for harmonization.

Nevraumont A, Deltombe M, Bayart JL

Publication: Clin Chim Acta (2024) • Vol 562 • Page 119875PMID: 39013524View on PubMed

Purpose

This paper compared the stability of glucose in case-matched lithium heparin, sodium-fluoride potassium oxalate (NaF/KOx), and sodium-fluoride EDTA-citrate (FC Mix) plasma during a 6 h post-centrifugation storage timecourse at room temperature and in NaF/KOx and FC Mix blood specimens that were stored for up to 24 h at room temperature or 4°C before centrifugation. The effect of delayed centrifugation was also assessed in matched NaF/KOx and FC Mix specimens collected from patients after an overnight fast and from pregnant women during an oral glucose tolerance test (OGTT).

Conclusion

The mean glucose concentration was lower in lithium heparin than NaF/KOx or FC Mix specimens when specimens were analyzed within 15 min of centrifugation, resulting in a clinically relevant bias in lithium heparin specimen relative to the FC Mix specimen. While not clinically relevant, the bias in glucose levels in the NaF/KOx specimen relative to the FC Mix specimen increased with post-centrifugation storage at room temperature (0.53% after <15 min, 0.94% after 2 h, 1.71% after 4 h, and 2.32% after 6 h).

Glucose levels were comparable in NaF/KOx and FC Mix specimens when each was centrifuged within 5 min. The concentration of glucose declined in the NaF/KOx specimens when centrifugation was delayed but remained stable in the FC Mix tubes, resulting in a clinically relevant bias after a 30 min delay to centrifugation at room temperature or 4°C. Importantly, this bias was observed in two different studies using different patients. When FC Mix tubes were used in a study of 701 specimens collected from fasting patients rather than  NaF/Kox tubes, 149 additional patients had glucose levels above the threshold for impaired fasting glucose (≥5.55 mmol/L) and 18 additional patients had glucose levels greater than the threshold for diabetes (≥7.0 mmol/L). Similarly, when FC Mix tubes, as opposed to NaF/KOX tubes, were used to collect specimens from pregnant women during oral glucose tolerance testing, the number of specimens classified as pathological was higher in specimens with the longest delay to centrifugation. Consequently, the use of NaF/KOx tubes instead of FC Mix tubes resulted in 24 fewer women (of 109) diagnosed with gestational diabetes.

Studies (2)

Purpose

This study compared the stability of glucose in case-matched lithium heparin, sodium-fluoride potassium oxalate (NaF/KOx), and sodium-fluoride EDTA-citrate (FC Mix) plasma during 6 h of post-centrifugation storage at room temperature. Blood was collected from the antecubital vein of 20 healthy volunteers (10 men and 10 women, mean 35.1 years) into lithium heparin, NaF/KOx, and FC Mix tubes. Each tube was mixed by ten inversions and centrifuged at 2,870 g for 10 min within 5 min of venipuncture. Tubes were stored at room temperature and glucose was measured <15 min (referred to as 0 h), 2 h, 4 h and 6 h after centrifugation. Glucose was quantified using the Atellica CH Glucose Hexokinase 3 assay on an Atellica CH 930 analyzer. Clinically relevant bias was defined as a bias exceeding the EFLM desirable bias of 2.3%.

Summary of Findings

When specimens were analyzed within 15 min of centrifugation, the mean glucose concentration was lower in specimens in lithium heparin than NaF/KOx or FC Mix tubes (4.82 versus 4.90 and 4.95, respectively). Further, the lithium heparin specimen had a clinically relevant mean absolute bias of 3.08% relative to the FC Mix specimen.  The bias between the lithium heparin and FC Mix tube specimens remained relatively stable during post-centrifugation storage at room temperature (2.66% at 2 h, 3.18% at 4 h and 3.27% at 6 h). While not clinically relevant, the bias in glucose levels in the NaF/KOx specimen relative to the FC Mix specimen increased with post-centrifugation storage at room temperature (0.53% after <15 min, 0.94% after 2 h, 1.71% after 4 h, and 2.32% after 6 h).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Normal
  • Platforms

    CarbohydrateClinical chemistry/auto analyzer
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate/sodium fluoride EDTA
    Lithium heparin
    Sodium fluoride/potassium oxalate
    Biospecimen AcquisitionType of collection container/solution
    FC Mix tube
    Lithium heparin tube
    NaF/KOx tube
    StorageTime at room temperature
    2 h
    6 h
    <15 min (0 h)